Search research articles
Contact Us
Filters
Showing results (181-190 of 289) with videos related to
Page
of 29
Sort By:
Cancer Treatment and Research Communications
|
November 3, 2019
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study
Sebastiano Buti, Melissa Bersanelli, Alessandro Viansone, et al.
Prostate Cancer and Prostatic Diseases
|
May 3, 2025
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial
Alberto Dalla Volta, Francesca Valcamonico, Andrea Zivi, et al.
BJU International
|
February 6, 2021
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib
Guillermo de Velasco, Álvaro Ruiz-Granados, Oscar Reig, et al.
European Urology Oncology
|
September 23, 2019
Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study
Giuseppe Procopio, Giulia Apollonio, Francesco Cognetti, et al.
Clinical Genitourinary Cancer
|
December 31, 2024
A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE)
Michael Staehler, Umberto Basso, Jean-Christophe Eymard, et al.
Plos One
|
April 12, 2016
Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis
Paolo Grassi, Ludovic Doucet, Palma Giglione, et al.
Plos One
|
July 7, 2018
Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy
Maria Giuseppa Vitale, Sarah Scagliarini, Luca Galli, et al.
Targeted Oncology
|
January 7, 2015
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy
Matteo Santoni, Sebastiano Buti, Alessandro Conti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 11, 2019
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
Ugo De Giorgi, Giuseppe Procopio, Diana Giannarelli, et al.
JMIR Cancer
|
January 22, 2025
Patient Voices: Multimethod Study on the Feasibility of Implementing Electronic Patient-Reported Outcome Measures in a Comprehensive Cancer Center
Cinzia Brunelli, Sara Alfieri, Emanuela Zito, et al.
Page
of 29
Search research articles
Search
Showing results (181-190 of 289) with videos related to
Sort By:
Page
of 29
Cancer Treatment and Research Communications
|
November 3, 2019
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study
Sebastiano Buti, Melissa Bersanelli, Alessandro Viansone, et al.
Prostate Cancer and Prostatic Diseases
|
May 3, 2025
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial
Alberto Dalla Volta, Francesca Valcamonico, Andrea Zivi, et al.
BJU International
|
February 6, 2021
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib
Guillermo de Velasco, Álvaro Ruiz-Granados, Oscar Reig, et al.
European Urology Oncology
|
September 23, 2019
Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study
Giuseppe Procopio, Giulia Apollonio, Francesco Cognetti, et al.
Clinical Genitourinary Cancer
|
December 31, 2024
A Prospective Non-interventional Real-World Study of cabozantinib in Pretreated Patients With Advanced Renal Cell Carcinoma Refractory to Vascular Endothelial Growth Factor-Targeted Therapy (CASSIOPE)
Michael Staehler, Umberto Basso, Jean-Christophe Eymard, et al.
Plos One
|
April 12, 2016
Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis
Paolo Grassi, Ludovic Doucet, Palma Giglione, et al.
Plos One
|
July 7, 2018
Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy
Maria Giuseppa Vitale, Sarah Scagliarini, Luca Galli, et al.
Targeted Oncology
|
January 7, 2015
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy
Matteo Santoni, Sebastiano Buti, Alessandro Conti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 11, 2019
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
Ugo De Giorgi, Giuseppe Procopio, Diana Giannarelli, et al.
JMIR Cancer
|
January 22, 2025
Patient Voices: Multimethod Study on the Feasibility of Implementing Electronic Patient-Reported Outcome Measures in a Comprehensive Cancer Center
Cinzia Brunelli, Sara Alfieri, Emanuela Zito, et al.
Page
of 29